Viridian Therapeutics entered mark up phase

VRDN has been in an accumulation phase since 2020.

Moreover, the price has recently moved above EMAs (10, 21 and 30) with price gap and significant volume increase.

I think price will continue its mark up phase in the next days.

IMPORTANT: This is not financial advice.